Matches in Wikidata for { <http://www.wikidata.org/entity/Q92520642> ?p ?o ?g. }
- Q92520642 description "2020 nî lūn-bûn" @default.
- Q92520642 description "2020年の論文" @default.
- Q92520642 description "2020年学术文章" @default.
- Q92520642 description "2020年学术文章" @default.
- Q92520642 description "2020年学术文章" @default.
- Q92520642 description "2020年学术文章" @default.
- Q92520642 description "2020年学术文章" @default.
- Q92520642 description "2020年学术文章" @default.
- Q92520642 description "2020年學術文章" @default.
- Q92520642 description "2020年學術文章" @default.
- Q92520642 description "2020年學術文章" @default.
- Q92520642 description "2020年學術文章" @default.
- Q92520642 description "2020年學術文章" @default.
- Q92520642 description "2020년 논문" @default.
- Q92520642 description "article científic" @default.
- Q92520642 description "article scientific" @default.
- Q92520642 description "article scientifique" @default.
- Q92520642 description "articol științific" @default.
- Q92520642 description "articolo scientifico" @default.
- Q92520642 description "artigo científico" @default.
- Q92520642 description "artigo científico" @default.
- Q92520642 description "artigo científico" @default.
- Q92520642 description "artikel ilmiah" @default.
- Q92520642 description "artikull shkencor" @default.
- Q92520642 description "artikulong pang-agham" @default.
- Q92520642 description "artykuł naukowy" @default.
- Q92520642 description "artículo científico publicado en 2020" @default.
- Q92520642 description "artículu científicu" @default.
- Q92520642 description "bilimsel makale" @default.
- Q92520642 description "bài báo khoa học" @default.
- Q92520642 description "naučni članak" @default.
- Q92520642 description "scienca artikolo" @default.
- Q92520642 description "scientific article published on 06 January 2020" @default.
- Q92520642 description "scientific article published on 6 January 2020" @default.
- Q92520642 description "scientific article published on 6 January 2020" @default.
- Q92520642 description "teaduslik artikkel" @default.
- Q92520642 description "tieteellinen artikkeli" @default.
- Q92520642 description "tudományos cikk" @default.
- Q92520642 description "vedecký článok" @default.
- Q92520642 description "vetenskaplig artikel" @default.
- Q92520642 description "videnskabelig artikel udgivet 6. januar 2020" @default.
- Q92520642 description "vitenskapelig artikkel" @default.
- Q92520642 description "vitskapeleg artikkel" @default.
- Q92520642 description "vědecký článek" @default.
- Q92520642 description "wetenschappelijk artikel" @default.
- Q92520642 description "wissenschaftlicher Artikel" @default.
- Q92520642 description "επιστημονικό άρθρο" @default.
- Q92520642 description "мақолаи илмӣ" @default.
- Q92520642 description "наукова стаття, опублікована в січні 2020" @default.
- Q92520642 description "научна статия" @default.
- Q92520642 description "научная статья" @default.
- Q92520642 description "научни чланак" @default.
- Q92520642 description "научни чланак" @default.
- Q92520642 description "מאמר מדעי" @default.
- Q92520642 description "مقالة علمية نشرت في 6 يناير 2020" @default.
- Q92520642 description "৬ জানুয়ারি ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q92520642 description "บทความทางวิทยาศาสตร์" @default.
- Q92520642 description "სამეცნიერო სტატია" @default.
- Q92520642 name "A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib" @default.
- Q92520642 name "A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib" @default.
- Q92520642 type Item @default.
- Q92520642 label "A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib" @default.
- Q92520642 label "A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib" @default.
- Q92520642 prefLabel "A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib" @default.
- Q92520642 prefLabel "A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib" @default.
- Q92520642 P1433 Q92520642-656ECCB0-5E06-4774-8FCD-0EB55B9D7F01 @default.
- Q92520642 P1476 Q92520642-1526882D-65B3-4CAF-A9A7-AE32E4373A7D @default.
- Q92520642 P2093 Q92520642-6E66AC93-E364-42B3-A644-89D0C7AF2BAB @default.
- Q92520642 P2093 Q92520642-7E0E19EF-2D5D-4968-8D96-83E6F6857DFA @default.
- Q92520642 P2093 Q92520642-C6FBC8DF-79DD-4997-B82E-C61BC8CCC870 @default.
- Q92520642 P304 Q92520642-0A9D5137-387E-4ADC-9409-6E628C7B1656 @default.
- Q92520642 P31 Q92520642-D1884DB3-5116-49BB-9FC3-EC729F65C224 @default.
- Q92520642 P356 Q92520642-272A676D-1459-4C95-83B6-EF93DFC74042 @default.
- Q92520642 P478 Q92520642-B77BE03A-70A1-4DCF-9129-01BEC538EF60 @default.
- Q92520642 P50 Q92520642-017B5897-25AB-4562-9730-AC88A916AABA @default.
- Q92520642 P50 Q92520642-21202674-A1B0-49B4-8C1D-C986CBDCC5C2 @default.
- Q92520642 P50 Q92520642-2F7353C7-F685-4085-B015-9EB38BEE5FB1 @default.
- Q92520642 P50 Q92520642-32A43271-A994-4B80-9621-3A2F8C246E51 @default.
- Q92520642 P50 Q92520642-405EBCE3-D91E-41F9-9D06-5AA193248B43 @default.
- Q92520642 P50 Q92520642-4CAEA59A-0B69-4322-9BB3-20B8DE22CB47 @default.
- Q92520642 P50 Q92520642-6F6B6F06-2F62-4AA9-95DD-BCBB64C86FE9 @default.
- Q92520642 P50 Q92520642-71784727-353E-44E5-8E78-039411D74235 @default.
- Q92520642 P50 Q92520642-A491991D-0B7C-478D-8C12-7857EAB3F3AF @default.
- Q92520642 P50 Q92520642-A744B16C-C948-47DC-9647-564FA8622BD3 @default.
- Q92520642 P50 Q92520642-CCB5E2E6-8B25-4DD2-8440-272411B64999 @default.
- Q92520642 P50 Q92520642-DAB80AFF-8F8A-450D-A693-5CB2A8FD9189 @default.
- Q92520642 P50 Q92520642-DAC3FE73-42A5-4198-B62D-4DCABCD28FDE @default.
- Q92520642 P50 Q92520642-DEAA9511-49C1-49AD-AF3B-1E2D2EE605DB @default.
- Q92520642 P50 Q92520642-EC5AB598-9B25-4084-BB7C-62B7585B6AFD @default.
- Q92520642 P50 Q92520642-F14EFDCF-F57B-4A08-8A15-7D52223D9AD6 @default.
- Q92520642 P50 Q92520642-FDB772BA-3AD3-4E41-B3B3-CD91929739EC @default.
- Q92520642 P577 Q92520642-ED9FF71B-915B-45ED-BC05-C42C734ED860 @default.
- Q92520642 P698 Q92520642-311FFCE3-3B84-488D-874A-30DFE52BFC5B @default.
- Q92520642 P921 Q92520642-1760DF7B-90E9-4930-99EE-F71B57FDB5A3 @default.
- Q92520642 P356 J.EJCA.2019.12.001 @default.
- Q92520642 P698 31918233 @default.
- Q92520642 P1433 Q332260 @default.
- Q92520642 P1476 "A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib" @default.
- Q92520642 P2093 "Antoine Italiano" @default.
- Q92520642 P2093 "Lucie Laroche" @default.